IGXT ($0.76) - Still eying it here. Recent positive results from a comparative bioavailability study with RHB-103 didn't seem to move that much. Let's see if it can hit $0.80 (don't know why but this would be where I would come in).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.